AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) Reports Second Quarter 2013 Financial Results

Published: Aug 08, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AVEO Oncology (NASDAQ: AVEO) today reported second quarter 2013 financial results.

“We are moving forward as an organization and are firmly focused on executing our revised business strategy,” said Tuan Ha-Ngoc, president and chief executive officer of AVEO. “We continue to advance our programs in clinical development, including tivozanib in colorectal and breast cancer, which are currently in Phase 2 studies.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news